Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab
December 06, 2021
From Benzinga
Canada, Merck Ink Supply Pact For 1M Doses Of Molnupiravir For COVID-19
December 06, 2021
Tickers
MRK
From Benzinga
Lilly's COVID-19 Antibody Cocktail Scores FDA Emergency Use For Kids, Including Newborns
December 06, 2021
From Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
December 06, 2021
Tickers
MOLN
From Benzinga
Moderna's President Hoge Sees 'Reboot' Of Existing Shots If Efficacy Falls 50%: Bloomberg
December 06, 2021
Tickers
MRNA
From Benzinga
Pfizer/BioNTech's COVID-19 Shot Receives Emergency Use Nod In Australia For Kids Aged 5-11 Years
December 06, 2021
From Benzinga
From Benzinga
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
From Benzinga
Europe To Start Deliveries Of Pfizer/BioNTech COVID-19 Shot For Children One Week Ahead Of Plan: Reuters
December 02, 2021
From Benzinga
From Benzinga
Codiak's COVID-19 Vaccine Hopeful Shows Potential In Preclinical Study
December 02, 2021
Tickers
CDAK
From Benzinga
After FDA Rejection, Humanigen's COVID-19 Drug Hopeful Sees Some Light Of Good News
December 02, 2021
Tickers
HGEN
From Benzinga
Britain Agrees To New Deals For 114M Additional Moderna, Pfizer/BioNTech COVID-19 Vaccine Doses
December 02, 2021
From Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
From Benzinga
Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
December 01, 2021
From Benzinga
AdComm Narrowly Backs Merck's COVID-19 Pill, Despite Efficacy Questions
December 01, 2021
From Benzinga
HC Wainwright Sees 'Buying Opportunity' For This COVID-19 Antibody Stock After Sell-Off
November 30, 2021
Tickers
REGN
From Benzinga
Why Did HC Wainwright Beef Up Vir Biotech's Target Price?
November 30, 2021
From Benzinga
GBS Shares Are Rallying On Plans For COVID-19 Antibody Trials After Validation Study
November 30, 2021
Tickers
GBS
From Benzinga
First Wave BioPharma Stock Jumps On Niclosamide's Favorable Safety Profile In COVID-19 Related GI Infections
November 30, 2021
Tickers
FWBI
From Benzinga
Moderna CEO Says Omicron Variant To Likely Hit COVID-19 Vaccines Effectiveness: FT
November 30, 2021
Tickers
MRNA
From Benzinga
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
November 30, 2021
From Benzinga
FDA May Authorize Pfizer-BioNTech COVID-19 Booster Shots For Age 16-17 Next Week: WSJ
November 30, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.